Can a ketamine boost during surgery slash opioid needs?
NCT ID NCT03231683
First seen Aug 14, 2026 · Last updated Aug 14, 2026
Summary
This trial tests whether giving a low dose of ketamine during anesthesia can reduce the amount of morphine needed for pain relief in the first 24 hours after an abdominal hysterectomy. It also looks at whether this approach lowers common opioid side effects like nausea, vomiting, and itching. The study involves 90 women undergoing open hysterectomy for benign conditions, with half receiving ketamine and half receiving a placebo, in a double-blinded setup.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Low-dose esketamine (S+ ketamine) given intravenously during anesthesia
- What this could lead to
- If effective, this could offer a way to reduce opioid use and related side effects after hysterectomy, improving recovery.
- What could go wrong
- This is a small, early-phase trial, so results may not be conclusive. Ketamine can cause side effects like nausea or psychotomimetic effects, and the benefit over placebo is uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2
Tests whether the treatment actually works, and watches for side effects, in a larger group.
- Participants
-
90 people
The number who actually took part.
- Start date
-
Mar 2014
- Finished
-
May 2016
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Female ASA I/II patients above age of 21 years old scheduled gynecological open surgery for benign condition (fibroids, adenomyosis), who are willing and able to give written informed consent for participation in this study. Exclusion Criteria: * Contraindications to the use of S+ ketamine, as listed in the product label e.g. untreated or insufficiently treated thyroid hyperfunction, unstable angina pectoris or myocardial infarction within the last 6 months, diseases of the central nervous system, increased intraocular pressure and perforating ocular injuries, surgical procedures in the upper respiratory tract; * History of drug or alcohol abuse; * Regular use of analgesics, or use of opioids within 12 hours of surgery; * Chronic use of benzodiazepine or neuroleptics; * Thyroid replacement hormone; * History of ischaemic heart disease, hypertension, psychiatric disorder; * BMI\> 30kg/m2; * Laparoscopic surgery converted to open surgery; * Pregnant or breast feeding females.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anesthesia are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kk Women'S and Children'S Hospital
Singapore, 229899, Singapore
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ketamine infusion tested against unrelenting cancer pain
- Can a gentler anesthesia cocktail protect a child's developing brain?
- Which monitor reads a Child's pain best during surgery?
- Propofol vs. inhaled anesthesia: which one spares your recovery?
- Which epidural technique best handles a cesarean emergency?
- Could a sleep drug shield older hearts from post-surgery delirium?